from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2867c/-

LFCtreatmentdescriptionclass of inhibitor

-0.222

Amikacinug/mL Amikacintranslation

-0.459

Cap5-10ug/mL Capreomycintranslation

-0.074

Rox10-50 ug/mL Roxithromycintranslation

0.321

SM2-5 ug/mL Streptomycintranslation

0.135

Tet5-10 ug/mL Tetracyclinetranslation

1.550

Rif0.2-5ug/mL Rifampicintranscription

0.060

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.349

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.478

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.727

CPZ10-50 ug/mL Chlorpromazinerespiration

0.199

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.247

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.378

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.070

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.127

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.395

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.655

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.667

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.592

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.913

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.580

KCN5-20 ug/mL Potassium cyaniderespiration

0.008

NaN30.2-2 mM Sodium aziderespiration

-0.314

Nigericin50 uM Nigericinrespiration

0.549

TRC10-150 ug/mL Triclosanrespiration

-0.014

TRZ10-25 ug/mL Thioridazinerespiration

-0.127

Valinomycin0.5-10 uM Valinomycinrespiration

-1.421

ZnSO42 mM ZnSO4respiration

-1.229

menadione6-10 ug/mL Menadionerespiration

-0.145

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.037

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.584

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.246

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.494

NRP_1Non-replicating persistence stage 1dosRassociated

0.164

Amp0.2mg/mL AmpicillincellWall

-0.847

Cephalexin20-100 ug/mL CephalexincellWall

-1.271

Cerulenin0.32-5 ug/mL CerulenincellWall

0.043

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.062

EMB10-20 ug/mL EthambutolcellWall

-0.427

Eta12-40 ug/mL EthionamidecellWall

-0.694

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.257

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.105

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.624

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.565

BZA0.12 mg/mL BenzamidearomaticAmides

0.262

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.070

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.327

H2O24 mM hydrogen peroxideDNAdamaging

-0.727

Levo10 ug/mL LevofloxacinDNAdamaging

-0.763

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.045

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.571

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.230

UVUV-irradiationDNAdamaging

-0.964

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.924

Antimycin12.5-50 ug/mL Antimycin A?

-1.081

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.092

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.660

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.235

PA8240.2-2 ug/mL PA-824?

1.204

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.185

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.164

Verapamil50 uM Verapamil?

-0.773

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.313

methoxatin10-20 ug/mL Methoxatin?